<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05615701</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL22_0298</org_study_id>
    <nct_id>NCT05615701</nct_id>
  </id_info>
  <brief_title>Image Quality of EOSedge for Radiographic Evaluation of Hip Implant</brief_title>
  <acronym>PreHIPEOS</acronym>
  <official_title>Image Quality of the EOSedge Radiographic System Versus a Standard Digital Radiographic (DR) System for Preoperative Assessment for Hip Replacement or Revision Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      EOSedge is a precise, low dose imaging system that delivers full body, high-quality images&#xD;
      covering the full set of musculoskeletal and orthopedic exams.&#xD;
&#xD;
      The objective of the study is to evaluate the quality of the focused pelvis/hip X-ray images&#xD;
      on EOSedge compared to those performed on DR (current practice) to perform a preoperative&#xD;
      radiographic evaluation of hip implant, A sufficient image quality on focused X-ray images&#xD;
      performed on EOSedge would allow (1) to avoid the passage on two different radiographic&#xD;
      systems (saving time) (2) to reduce the patient's x-ray radiation dose&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2022</start_date>
  <completion_date type="Anticipated">November 3, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 3, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score of Image quality</measure>
    <time_frame>Day 0</time_frame>
    <description>Each criteria is quantitative and combined to obtain a final quantitative score :&#xD;
Perfect reproduction = 2 / Moderate reproduction = 1 / Poor or uninterpretable reproduction = 0&#xD;
Artifacts ? = no or absence of periprosthetic material = 1; YES = 0&#xD;
X-ray image acceptable ? = Fully acceptable = 2; Acceptable only under limited clinical conditions = 1; Unacceptable (indicate why) = 0; OUTOCOME = FINAL SCORE&#xD;
European C, Directorate-General for R, Innovation, Carmichael J, Moores B, Maccia C. Guide européen relatif aux critères de qualité des clichés de radiodiagnostic: Publications Office, 2000.&#xD;
Kogon PL, Lumsden R. How do you critique your radiographs? The Journal of the Canadian Chiropractic Association. 1993; 37(4):230-232.&#xD;
Cook JV, Kyriou JC, Pettet A, Fitzgerald MC, Shah K, Pablot SM. Key factors in the optimization of paediatric X-ray practice. The British journal of radiology. 2001; 74(887):1032-1040.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dosimetry</measure>
    <time_frame>Day 0</time_frame>
    <description>The X-ray exposure dose induced by standard radiography and EOSedge will be compared.&#xD;
The radiation delivered to the patient during standard and EOSedge radiography will be quantified according to the dose × area product (DAP) [Gy.cm2] (dose * area product), for each exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosimetry</measure>
    <time_frame>Day 0</time_frame>
    <description>The X-ray exposure dose induced by standard radiography and EOSedge will be compared.&#xD;
The radiation delivered to the patient during standard and EOSedge radiography will be quantified according to the entry dose [mGy]</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <condition>Hip Prosthesis Infection</condition>
  <arm_group>
    <arm_group_label>EOSedge imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm study : All subjects include in the study underwent micro-dose EOS x-ray and digital radiography for radiographic evaluation of hip implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>EOSedge imaging</intervention_name>
    <description>Hip X-ray evaluation in an EOSedge imaging for preoperative assessment for hip replacement or revision surgery</description>
    <arm_group_label>EOSedge imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient 18 years of age or older&#xD;
&#xD;
          -  Came to the imaging department to perform a preoperative assessment for hip&#xD;
             replacement or revision&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under guardianship or curatorship&#xD;
&#xD;
          -  Patient participating in an interventional study&#xD;
&#xD;
          -  Patient unable to read and/or write&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine c-cyteval@chu-montpellier.fr, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement of Medical Imaging - Montpellier University hospital LAPEYRONIE Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine CYTEVAL, MD, PhD</last_name>
    <phone>0467338178</phone>
    <phone_ext>+33</phone_ext>
    <email>c-cyteval@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Departement of Medical Imaging</name>
      <address>
        <city>Montpellier</city>
        <state>Occitanie</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celine ENGRAND</last_name>
      <email>c-engrand@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>October 27, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 23, 2022</last_update_submitted>
  <last_update_submitted_qc>November 23, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EOS</keyword>
  <keyword>Radiography</keyword>
  <keyword>Hip</keyword>
  <keyword>Hip replacement</keyword>
  <keyword>Image quality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

